معرفی
Professor Vignir G Helgason is a Reader in Cancer Research at the Institute of Cancer Sciences, University of Glasgow, and leads the Helgason Laboratory at the Wolfson Wohl Cancer Research Centre. His work is centered on translational leukemia research, particularly focusing on leukemia stem cells, autophagy, and cancer metabolism.
Education & Training:
- B.Sc. in Biology, University of Iceland (2000)
- Ph.D. in Tumour Cell Death Laboratory, Cancer Research UK Beatson Institute, University of Glasgow (2007)
- Post-doctoral training, Paul O’Gorman Leukaemia Research Centre
Research Focus:
Dr. Helgason’s team employs a "bench to bedside" approach, targeting leukemia stem cells to overcome drug resistance. Key areas include:
- Chronic Myeloid Leukemia (CML) biology
- Autophagy in leukemia stem cell survival
- Cancer metabolism and mitochondrial targeting
- Leukemia niche interactions
Scientific Awards:
- Kay Kendall Leukaemia Fund Research Fellowship
- John Goldman Fellowship for Future Science
- University of Glasgow Leadership Fellowship
Grants & Funding:
His research is supported by major grants from Leukaemia UK, Blood Cancer UK, Cancer Research UK, Medical Research Council (MRC), and Wellcome Trust, among others.
Laboratory & Team:
He leads the Helgason Laboratory (Leukaemia and Autophagy Therapeutics) at the Tommy Burns Laboratory, fostering interdisciplinary collaborations and training the next generation of cancer researchers.
